Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy

scientific article

Medulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2014PLoSO...999490Z
P356DOI10.1371/JOURNAL.PONE.0099490
P932PMC publication ID4059646
P698PubMed publication ID24932704
P5875ResearchGate publication ID263131976

P2093author name stringPing Zhong
Jian Xu
Ying Mao
Yong Ren
Zhen-Yu Zhang
Yu Yao
Ho-Keung Ng
Liang-Fu Zhou
Kay Ka-Wai Li
P2860cites workMedulloblastoma: experience of a single institution.Q55477502
Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.Q55481597
Molecular subgroups of medulloblastoma: the current consensusQ24615271
The 2007 WHO classification of tumours of the central nervous systemQ24685772
Epidemiology of primary brain tumors: current concepts and review of the literatureQ30501715
Metastasis stage, adjuvant treatment, and residual tumor are prognostic factors for medulloblastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study.Q33539849
Outcome and prognostic factors of desmoplastic medulloblastoma treated within a multidisciplinary treatment conceptQ33669523
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomasQ34167499
Medulloblastoma: clinical and biologic aspectsQ34364285
Current multimodality management of medulloblastomaQ35007079
Radiation treatment for medulloblastoma: a review of 64 cases at a single instituteQ36059176
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsQ36460209
Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adultsQ36820329
Medulloblastoma comprises four distinct molecular variantsQ36920479
Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.Q37198737
Management of and prognosis with medulloblastoma: therapy at a crossroadsQ37322966
Medulloblastoma in children under the age of three years: a retrospective Canadian reviewQ37382230
Long-term outcome and clinical prognostic factors in children with medulloblastoma treated in the prospective randomised multicentre trial HIT'91.Q39875833
Medulloblastoma in adults.Q40442869
Effects of medulloblastoma resections on outcome in children: a report from the Children's Cancer GroupQ41162667
Current therapy and new perspectives in the treatment of medulloblastomaQ41735764
Improved survival with the use of adjuvant chemotherapy in the treatment of medulloblastomaQ43617614
Postoperative radiation therapy for medulloblastoma--high recurrence rate in the subfrontal regionQ44161027
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialQ45120061
Influence of a child's sex on medulloblastoma outcome.Q45986392
Do children and adults differ in survival from medulloblastoma? A study from the SEER registryQ46866980
Adult medulloblastoma: prognostic factors and response to therapy at diagnosis and at relapseQ48764303
Prognosis and long-term follow-up in patients with medulloblastomaQ48820345
Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Retrospective study of 156 patients.Q50599689
Outcome and prognostic factors of radiation therapy for medulloblastoma.Q51054174
Survival and prognostic factors in a series of adults with medulloblastomas.Q51872092
Medulloblastoma in adults: a series from Brazil.Q53662864
Adult medulloblastoma: clinical profile and treatment results of 18 patients.Q55467528
Long-term results of a prospective study on the treatment of medulloblastoma in adults.Q55467796
Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.Q55473265
Adult medulloblastoma: prognostic factors and patterns of relapse.Q55475197
Medulloblastoma: time-dose relationship based on a 30-year review.Q55477493
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectmedulloblastomaQ1333608
P304page(s)e99490
P577publication date2014-06-16
P1433published inPLOS OneQ564954
P1476titleMedulloblastoma in China: clinicopathologic analyses of SHH, WNT, and non-SHH/WNT molecular subgroups reveal different therapeutic responses to adjuvant chemotherapy
P478volume9

Reverse relations

cites work (P2860)
Q33665382A Retrospective Study of Progression-Free and Overall Survival in Pediatric Medulloblastoma Based on Molecular Subgroup Classification: A Single-Institution Experience
Q36383466IL-17 promoted the inhibition of medulloblastoma in mice by splenocyte injection
Q50604253Medulloblastoma: selecting children for reduced treatment.
Q39134342Modern management of medulloblastoma: Molecular classification, outcomes, and the role of surgery
Q90101021Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma
Q41989047Risk factors for the prognosis of pediatric medulloblastoma: a retrospective analysis of 40 cases
Q38703533The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis.